These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 8193356)
1. Relative antithrombotic effects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in nonhuman primates. Cadroy Y; Hanson SR; Kelly AB; Marzec UM; Evatt BL; Kunicki TJ; Montgomery RR; Harker LA Blood; 1994 Jun; 83(11):3218-24. PubMed ID: 8193356 [TBL] [Abstract][Full Text] [Related]
2. Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in nonhuman primates. Cauwenberghs N; Meiring M; Vauterin S; van Wyk V; Lamprecht S; Roodt JP; Novák L; Harsfalvi J; Deckmyn H; Kotzé HF Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1347-53. PubMed ID: 10807753 [TBL] [Abstract][Full Text] [Related]
3. Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon. Hanson SR; Pareti FI; Ruggeri ZM; Marzec UM; Kunicki TJ; Montgomery RR; Zimmerman TS; Harker LA J Clin Invest; 1988 Jan; 81(1):149-58. PubMed ID: 2961790 [TBL] [Abstract][Full Text] [Related]
4. Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factor. Depraetere H; Ajzenberg N; Girma JP; Lacombe C; Meyer D; Deckmyn H; Baruch D Blood; 1998 May; 91(10):3792-9. PubMed ID: 9573016 [TBL] [Abstract][Full Text] [Related]
5. Antihemostatic and antithrombotic effects of monoclonal antibodies against von Willebrand factor in nonhuman primates. Krupski WC; Bass A; Cadroy Y; Kelly AB; Harker LA; Hanson SR Surgery; 1992 Aug; 112(2):433-9; discussion 439-40. PubMed ID: 1641780 [TBL] [Abstract][Full Text] [Related]
6. Effects of an antiplatelet glycoprotein Ib antibody on hemostatic function in the guinea pig. Becker BH; Miller JL Blood; 1989 Aug; 74(2):690-4. PubMed ID: 2752142 [TBL] [Abstract][Full Text] [Related]
7. Interruption of vascular thrombosis by bolus anti-platelet glycoprotein IIb/IIIa monoclonal antibodies in baboons. Krupski WC; Bass A; Kelly AB; Ruggeri ZM; Harker LA; Hanson SR J Vasc Surg; 1993 Feb; 17(2):294-303; discussion 303-4. PubMed ID: 8433425 [TBL] [Abstract][Full Text] [Related]
8. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Alevriadou BR; Moake JL; Turner NA; Ruggeri ZM; Folie BJ; Phillips MD; Schreiber AB; Hrinda ME; McIntire LV Blood; 1993 Mar; 81(5):1263-76. PubMed ID: 8443388 [TBL] [Abstract][Full Text] [Related]
9. Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb:IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Hantgan RR; Hindriks G; Taylor RG; Sixma JJ; de Groot PG Blood; 1990 Jul; 76(2):345-53. PubMed ID: 2369638 [TBL] [Abstract][Full Text] [Related]
10. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa. Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012 [TBL] [Abstract][Full Text] [Related]
11. Anti-human VWF monoclonal antibody SZ-123 prevents arterial thrombus formation by inhibiting VWF-collagen and VWF-platelet interactions in Rhesus monkeys. Zhao YM; Jiang M; Ji SD; He Y; Shen F; Li XM; Ruan CG Biochem Pharmacol; 2013 Apr; 85(7):945-53. PubMed ID: 23295157 [TBL] [Abstract][Full Text] [Related]
12. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Peterson DM; Stathopoulos NA; Giorgio TD; Hellums JD; Moake JL Blood; 1987 Feb; 69(2):625-8. PubMed ID: 3492225 [TBL] [Abstract][Full Text] [Related]
13. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked. Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936 [TBL] [Abstract][Full Text] [Related]
14. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors. De Marco L; Mazzuccato M; Grazia Del Ben M; Budde U; Federici AB; Girolami A; Ruggeri ZM J Clin Invest; 1987 Aug; 80(2):475-82. PubMed ID: 3038958 [TBL] [Abstract][Full Text] [Related]
16. Shear stress-induced binding of von Willebrand factor to platelets. Konstantopoulos K; Chow TW; Turner NA; Hellums JD; Moake JL Biorheology; 1997; 34(1):57-71. PubMed ID: 9176590 [TBL] [Abstract][Full Text] [Related]
17. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor. Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543 [TBL] [Abstract][Full Text] [Related]
18. von Willebrand factor competes with fibrin for occupancy of GPIIb:IIIa on thrombin-stimulated platelets. Hantgan RR; Nichols WL; Ruggeri ZM Blood; 1990 Feb; 75(4):889-94. PubMed ID: 2302458 [TBL] [Abstract][Full Text] [Related]
19. Antithrombotic effects of orally active synthetic antagonist of activated factor X in nonhuman primates. Yokoyama T; Kelly AB; Marzec UM; Hanson SR; Kunitada S; Harker LA Circulation; 1995 Aug; 92(3):485-91. PubMed ID: 7634464 [TBL] [Abstract][Full Text] [Related]
20. Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb. Naimushin YA; Mazurov AV Platelets; 2004 Nov; 15(7):419-25. PubMed ID: 15745313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]